MedPath

Esmolife

Brand Name: Esmolife

Generic Name: Esmolol hydrochloride

Active
Registration Number

DR-XY45702

Dosage Form

Solution for IV Injection

Issuance Date

September 24, 2021

Expiry Date

December 9, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10mg/ mL (100 mg/ 10 mL)
PackagingPh. Eur. Type I Amber Glass Vial in 10 mL (net content). Box of 5 and 10 vials.

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Beta Adrenoceptor Blocker
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Esmolol hydrochlorideActive
Monograph: Esmolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform